Submitted by Anonymous (not verified) on 11 October 2023 - 7:18
Human medicines European public assessment report (EPAR): Synagis, palivizumab, Respiratory Syncytial Virus Infections, Date of authorisation: 13/08/1999, Revision: 46, Status: Authorised
Source: